Clinical Evaluation Plan Analysis
Clinical Evaluation Plan analysis helps Clinical Affairs and Regulatory Affairs Teams evaluate clinical evidence strategy, GSPR and risk linkage, and MDR readiness before formal CEP approval decisions.
What Clinical Teams Can Decide From the Analysis
Is the CEP scope clear?
Identify if the Clinical Evaluation Plan defines device scope and lifecycle boundaries so teams can confirm review coverage before clinical governance approval.
Where could MDR gaps appear?
Spot missing GSPR traceability or PMCF linkages before they create MDR review risk or CER update delays downstream.
Can teams make a clearer approval decision?
Evaluate whether the Clinical Evaluation Plan provides enough clinical evidence rationale for reviewers to approve, revise, or escalate with confidence.
How Teams Use This Analysis
Clinical Affairs and Regulatory Affairs Teams use Clinical Evaluation Plan analysis to review clinical planning records more consistently, catch MDR compliance risk earlier, and turn cross-referenced methodologies into decisions about evidence planning and approval readiness.
Document Control Verification
Connects approval status to governance decisions, giving teams a clearer basis for document release, revision, and audit preparation.
Post-Market Surveillance Readiness Assessment
Turns scattered PMCF notes into structured findings, allowing post-market teams to prioritize CER updates, follow-up actions, and approval decisions.
Risk Management Document Review
Checks whether literature strategy evidence and linked risk references remain aligned, reducing the chance that teams rely on weak rationales or outdated references.
Cross-Standard Mapping
Surfaces missing acceptance criteria, broken GSPR links, and weak PMCF integration, giving clinical reviewers earlier visibility into MDR readiness risk before CEP reaches approval.
Information Gap Analysis
Organizes open equivalence questions and reviewer notes into a practical follow-up path, so unresolved issues can be addressed before they become submission delays.
Regulatory Gap Analysis
Maps MDR references and CEP scope into a clearer readiness view, helping regulatory teams understand Annex XIV alignment before governance review.
Key Clinical Evaluation Plan Insights to Look For
Automatan organizes Clinical Evaluation Plan evaluation into structured insights that help teams judge clinical evidence coverage, MDR alignment, governance readiness, and the quality of the evidence behind approval decisions.
Document Name
CEP title is captured to maintain revision traceability and avoid approval confusion across all clinical governance review cycles.
Document Type
The CEP type provides a consistent anchor for insights, ensuring the analysis stays linked to the correct clinical evaluation plan.
QMS Scope
A structured summary of device scope, lifecycle coverage, and clinical evaluation boundaries gives teams immediate context without scope misinterpretation.
Standards Alignment
Extracted MDR, MEDDEV, MDCG, ISO, and SOP references distinguish explicit commitments from implied intent, helping teams focus compliance planning where it matters most.
Document Control Verification
Classification of approved versus draft status clarifies which governance lens applies and directs early document control evidence collection.
Structural Completeness
Flags missing CEP sections to highlight elevated MDR scrutiny and prioritize review efforts.
Compliance Flags
Determines compliant or conflicting statement status to guide remediation assignment and review control expectations.
Traceability Integrity
Linked versus missing reference designation informs the correct traceability pathway and cross-document follow-up.
Clinical Evidence Strategy
Literature, clinical investigation, or equivalence signals shape evidence strategy and review priority decisions.
Acceptance Criteria Definition
Interaction with performance, safety, and benefit-risk thresholds is identified, ensuring acceptance criteria or review decisions are properly scoped.
GSPR & Risk Linkage
GSPR, residual risk, or benefit-risk signals provide clarity on evidence scope and ISO 14971 relevance.
PMCF Integration
Automated extraction of lifecycle context, such as PMCF planning or PSUR updates, informs governance readiness and evidence requirements.
Evaluator Qualifications
Directional competency and independence signals offer early insight for evaluator qualification planning.
QA Readiness Signal
Ready, Conditional, and Not Ready categories anchor approval reasoning and support governance mapping.
QA Readiness Findings
Identifies blocker, major, or minor findings to guide remediation, escalation, and approval decisions.
Reviewer Notes
Required expert clinical judgment signals inform follow-up planning and formal review decisions.
Who Uses This Analysis
Clinical Evaluation Plan review pulls in several stakeholders at once. Each group needs a different cut of the same document, focused on regulatory and clinical questions closest to its mandate.
Clinical Affairs Teams
Reads the Clinical Evaluation Plan for evidence strategy, using the analysis to decide whether clinical planning needs revision.
Regulatory Affairs Professionals
Reviews MDR and MEDDEV coverage, helping the team identify submission gaps before notified body review.
Quality Assurance Teams
Checks document control evidence and supporting references, making sure the plan can support approval and audit review.
Medical Safety & Risk Teams
Uses the analysis to compare benefit-risk linkage against ISO 14971 risk controls, giving stakeholders a clearer basis for escalation.
Post-Market Surveillance & PMCF Teams
Assesses the lifecycle integration to determine whether the CEP supports ongoing clinical evidence generation.
How Clinical Evaluation Plan Analysis Connects to Your Clinical Governance Workflow
Automatan works inside the tools Clinical Affairs and Regulatory Affairs Teams already use. Clinical Evaluation Plans and supporting files can be imported from common document sources and turned into structured clinical governance intelligence without rebuilding the approval process.
Google Drive
Import documents directly from Google Drive so Automatan can extract MDR references and readiness indicators from files already stored by the team.
Add AI Integration
Google Docs
Analyze Clinical Evaluation Plans stored in Google Docs without moving files, enabling seamless extraction of clinical evidence insights within the existing workspace.
Add AI Integration
OneDrive
Access documents from OneDrive so teams in regulated medical device environments can capture traceability signals directly from their repository.
Add AI Integration
Dropbox
Pull clinical evaluation plans from Dropbox to turn embedded PMCF signals, GSPR links, and reviewer notes into structured governance intelligence inside Automatan.
Add AI IntegrationAnalyze Clinical Evaluation Plans With Clearer Clinical Evidence
Clinical Affairs and Regulatory Affairs Teams need more than narrative. Automatan helps teams analyze Clinical Evaluation Plans for clinical evidence strategy, MDR readiness, and follow-up actions, so every review leads to clearer approval decisions.